This quiz collection focuses on stability testing protocols — batch selection, storage conditions, sampling strategies, and shelf-life calculation — tailored for M.Pharm students studying Advanced Pharmaceutical Analysis (MPA 102T). It covers regulatory expectations (ICH guidelines), practical design choices such as bracketing and matrixing, worst-case selection for container-closure systems, typical storage conditions for different climatic zones, sampling schedules, stress and photostability testing, and statistical approaches for shelf-life estimation. Each question is designed to test conceptual understanding and application in formulation development and regulatory submissions, helping students prepare for exams and real-world stability study design and data interpretation.
Q1. Which ICH guideline primarily governs stability testing of new drug substances and products?
- ICH Q1A(R2)
- ICH Q6A
- ICH Q8(R2)
- ICH Q7
Correct Answer: ICH Q1A(R2)
Q2. According to regulatory guidance, what is the minimum recommended number of batches for long-term stability studies of a new drug product?
- One full-scale batch
- Two pilot-scale batches
- Three production-scale batches
- Five laboratory-scale batches
Correct Answer: Three production-scale batches
Q3. What best describes the concept of “bracketing” in stability study design?
- Testing all strengths and container sizes at every time point
- Testing only the extremes of certain factors (e.g., strengths, container sizes) during a study
- Testing a random subset of batches across all conditions
- Conducting only accelerated studies and extrapolating to long-term
Correct Answer: Testing only the extremes of certain factors (e.g., strengths, container sizes) during a study
Q4. What does “matrixing” refer to in stability testing?
- Testing only drug substance and ignoring the finished product
- Testing each time point with all possible analytical tests
- Testing different subsets of samples at different time points to reduce testing burden
- Applying accelerated conditions across all batches
Correct Answer: Testing different subsets of samples at different time points to reduce testing burden
Q5. What are the standard accelerated stability conditions recommended by ICH for most drug products?
- 25 ± 2°C / 60 ± 5% RH
- 40 ± 2°C / 75 ± 5% RH
- 30 ± 2°C / 65 ± 5% RH
- 5 ± 3°C (refrigerated)
Correct Answer: 40 ± 2°C / 75 ± 5% RH
Q6. Which is a typical long-term storage condition for products intended for climatic Zone II?
- 30 ± 2°C / 65 ± 5% RH
- 40 ± 2°C / 75 ± 5% RH
- 25 ± 2°C / 60 ± 5% RH
- 5 ± 3°C
Correct Answer: 25 ± 2°C / 60 ± 5% RH
Q7. When is intermediate stability testing recommended?
- Only when photostability testing fails
- When accelerated conditions indicate significant change before proposed shelf-life
- For products stored below 0°C
- For all products regardless of accelerated study results
Correct Answer: When accelerated conditions indicate significant change before proposed shelf-life
Q8. Which guideline specifically addresses photostability testing of new drug substances and products?
- ICH Q1A(R2)
- ICH Q1B
- ICH Q2(R1)
- ICH Q3B
Correct Answer: ICH Q1B
Q9. For worst-case selection of container-closure systems, which container would typically be chosen?
- The container with the most aesthetically pleasing design
- The primary packaging with the highest potential to affect product stability (e.g., highest permeability)
- The smallest available container size regardless of material
- The container used for clinical trial supply only
Correct Answer: The primary packaging with the highest potential to affect product stability (e.g., highest permeability)
Q10. What is a commonly accepted minimum number of replicate containers to be tested per time point for physical/chemical assays in a stability study?
- One container is sufficient
- At least two containers
- At least three containers per time point to allow replicate testing
- Ten containers per time point
Correct Answer: At least three containers per time point to allow replicate testing
Q11. According to statistical approaches in stability (ICH Q1E), how is shelf-life often estimated from linear regression of potency versus time?
- Time when the mean potency equals zero
- Time when the upper 95% confidence limit intersects the specification limit
- Time when the lower 95% confidence limit from the regression intersects the acceptance criterion
- The average time to first out-of-specification result
Correct Answer: Time when the lower 95% confidence limit from the regression intersects the acceptance criterion
Q12. In first-order degradation kinetics, which plot gives a straight line?
- Concentration vs time
- ln(concentration) vs time
- 1/concentration vs time
- Square root of concentration vs time
Correct Answer: ln(concentration) vs time
Q13. What does the Q10 temperature coefficient approximately represent in stability predictions?
- Rate decreases by a factor of ten every 10°C rise
- Rate doubles for every 10°C rise (Q10 ≈ 2)
- Rate remains unchanged with temperature
- Rate becomes half for each 10°C rise
Correct Answer: Rate doubles for every 10°C rise (Q10 ≈ 2)
Q14. Which mathematical relationship is commonly used to relate degradation rate constants to temperature for accelerated stability extrapolation?
- Henderson-Hasselbalch equation
- Arrhenius equation
- Michaelis-Menten equation
- van’t Hoff equation for solubility only
Correct Answer: Arrhenius equation
Q15. Typical long-term stability sampling intervals recommended for many products include which sequence?
- 0, 1, 2, 3 months
- 0, 3, 6, 9, 12, 18, 24, 36 months
- Only 0 and final time point
- Every month up to 60 months
Correct Answer: 0, 3, 6, 9, 12, 18, 24, 36 months
Q16. Which statement is true about extrapolating shelf-life from accelerated data alone?
- Extrapolation is always acceptable without qualification
- Shelf-life extrapolated solely from accelerated data requires justification and supporting evidence from real-time data or mechanistic understanding
- Accelerated data can never be used for any shelf-life estimation
- Accelerated studies replace the need for long-term studies
Correct Answer: Shelf-life extrapolated solely from accelerated data requires justification and supporting evidence from real-time data or mechanistic understanding
Q17. What is a core requirement for a stability-indicating analytical method?
- High throughput without specificity
- Ability to separate and quantify the drug substance from its degradation products
- Only to measure impurities at release
- Exclusive use of UV detection methods
Correct Answer: Ability to separate and quantify the drug substance from its degradation products
Q18. The term “retest period” typically applies to which material?
- Finished dosage form (drug product)
- Active Pharmaceutical Ingredient (API)
- Packaging components only
- Placebo formulations
Correct Answer: Active Pharmaceutical Ingredient (API)
Q19. According to ICH Q1B, what are the recommended overall illumination and UV energy exposures for photostability testing?
- 200 lux hours and 1,000 watt-hours/m2 UV energy
- 1.2 million lux hours and 200 watt-hours/m2 UV energy
- 500,000 lux hours and 50 watt-hours/m2 UV energy
- No specific numerical exposures are provided
Correct Answer: 1.2 million lux hours and 200 watt-hours/m2 UV energy
Q20. What is the primary purpose of conducting stress (forced degradation) studies during drug development?
- To determine product color preferences
- To identify degradation pathways and help develop stability-indicating methods
- To replace long-term stability testing
- To test product palatability under extreme conditions
Correct Answer: To identify degradation pathways and help develop stability-indicating methods
